| Thailand | Turkey | South Korea | |
| Stem Cell Therapy | from AUD $2,611 / ฿A88,778 | from AUD $10,444 / ฿A355,110 | from AUD $1,039 / ฿A35,314 |
| Plasmapheresis | from AUD $3,191 / ฿A108,506 | from AUD $1,741 / ฿A59,185 | from AUD $6,093 / ฿A207,148 |
| Stem cell therapy for ALS (amyotrophic lateral sclerosis) | from AUD $36,265 / ฿A1,233,022 | from AUD $43,518 / ฿A1,479,626 | - |
Dr Kantaphong Thongrong is a board-certified physiatrist who previously presented his medical research at the 17th Ottawa Conference in Perth, Australia.
Dr Tara Rak-areekul ranked first in the National formative neurological examination, marking her as one of the top academic minds in Thai neurology.
Dr. Pongwat Polpong is a top neurosurgeon and specialist in regenerative medicine in Thailand. He has more than 15 years of experience in clinical practice, teaching, and research. He trained at Siriraj Hospital, the Neurological Institute of Thailand, and the International Neuroscience Institute in Germany.
Dr. Pongwat has published many research papers on neurosurgery, parasitology, spine disorders, and brain diseases. His work includes studies on percutaneous endoscopic lumbar discectomy, cerebral cysticercosis, spinal cord injury, and cerebrovascular disorders.
He performed Bangkok Hospital Chanthaburi’s first endoscopic transsphenoidal surgery, a minimally invasive treatment for pituitary tumors. As Chief Physician at EDNA Wellness, he leads programs in Stem Cell Therapy, Neurology, Bone and Joint Regeneration, and Nutrition Enhancement.
Thailand offers ALS treatment through mesenchymal stem cell (MSC) therapy and neurological rehabilitation. Major centres like Bumrungrad International provide standard medication like Riluzole. Specialist clinics such as EDNA Wellness and PYONG Rehabilitation Group focus on neuroprotection and intensive robotic gait training.
Bookimed Expert Insight: Many patients seek single injections. However, our data shows a trend toward multi-day protocols. Clinics like Vega Clinic offer stays up to 45 days. This allows for intensive monitoring alongside stem cell administration. Choosing clinics with 5-star hotel inclusions can simplify logistics for patients with mobility challenges.
Thai clinics manage respiratory failure from Amyotrophic lateral sclerosis (ALS) using international standards. These include non-invasive ventilation (NIV) and airway clearance. Major centres in Bangkok provide BiPAP machines alongside JCI-accredited care. Specialists work in multidisciplinary teams including neurologists and respiratory physios.
Bookimed Expert Insight: Many local clinics focus on regenerative therapies. However, patients with complex ALS symptoms should look for hospitals with integrated rehabilitation units. Dr Kantaphong Thongrong at PYONG Rehabilitation Group specialises in neurorehabilitation and robotic gait training. This specialist physiatry is essential for managing secondary ALS complications beyond just respiratory support.
Stem cell therapies for ALS are widely available in private Thai clinics. Providers use mesenchymal and umbilical cord stem cells to manage disease progression. These protocols often include intravenous drips or lumbar punctures. Major centres in Bangkok also integrate neurorehabilitation into treatment plans.
Bookimed Expert Insight: Thai clinics often bundle stem cell therapy with diagnostic testing. A typical package at ID Clinic Bangkok includes blood tests, chest X-rays, and preoperative screenings. This thorough assessment helps doctors tailor the high-dose MSC treatments. These can reach 80 million cells per session.
Patient Consensus: Patients consider these therapies as experimental rather than standard care. They recommend confirming if protocols have ethical oversight. Patients should discuss all overseas options with an Australian neurologist before travel.
Thailand clinics primarily manage ALS using Riluzole and Edaravone to slow functional decline. JCI-accredited facilities in Bangkok combine these with neurorehabilitation and mesenchymal stem cell therapies. Specialist neurologists oversee care to manage symptoms like spasticity and cramps alongside respiratory support.
Bookimed Expert Insight: Thailand combines standard pharmaceutical care with regenerative treatments. Major hospitals like Bumrungrad specialise in standard neurology. Boutique centres like EDNA Wellness and Plenary Wellness often partner with university laboratories. These partnerships allow them to offer mesenchymal stem cells. This provides a multi-layered approach that is harder to find in many other regions.
Patient Consensus: Patients in Thailand recommend checking if Riluzole and Edaravone are stocked locally. Some hospitals may require pre-ordering. They note that successful care depends on combining these drugs with feeding support and respiratory planning.
ALS care in Thailand involves a multidisciplinary diagnostic process at JCI-accredited hospitals like Bumrungrad International. Specialists use electromyography (EMG) and nerve conduction studies to confirm motor neuron loss. They also perform brain and spinal MRI scans and extensive blood work to rule out conditions that mimic ALS.
Bookimed Expert Insight: Major hospitals provide standard diagnostics. However, specialised clinics like EDNA Wellness partner with GMP-certified laboratories for regenerative research. This allows patients to combine definitive diagnostics with stem cell-based supportive care protocols. These facilities often provide teleconsultations for Australians to review their case before travelling.
Rehabilitation for ALS in Thailand uses a multidisciplinary approach at JCI-accredited centres. Specialists provide neuro-rehabilitation through physiotherapy, respiratory care, and robotic gait training. Facilities like PYONG Rehabilitation Group offer wearable exoskeletons. Regenerative therapies using mesenchymal stem cells are also common.
Bookimed Expert Insight: Thai rehabilitation clinics often integrate university-led research into patient care. Plenary Wellness collaborates with Prince of Songkla University on regenerative protocols. This provides patients access to research-backed mesenchymal stem cell dosages. These often range from 20 million to 80 million cells per session.